Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Tumour Diseases”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07237100
What this trial is testing

Mirdametinib in Patients With Advanced NF1-mutant Melanoma

Who this might be right for
Advanced Unresectable MelanomaMetastatic Melanoma
Kevin Kim, MD 10
Testing effectiveness (Phase 2)UnknownNCT05030077
What this trial is testing

Anlotinib Combined With Platinum/Gemcitabine for First Line Treatment of Advanced Urothelial Carcinoma

Who this might be right for
Urothelial CarcinomaAnlotinibUrogenital Neoplasms+4 more
Tianjin Medical University Second Hospital 53
Not applicableStudy completedNCT02805530
What this trial is testing

Radical Treatment of Synchronous Oligometastatic Non-Small Cell Lung Carcinoma

Who this might be right for
Carcinoma, Non-Small-Cell LungSynchronous Neoplasms
Instituto Nacional de Cancerologia de Mexico 36
Testing effectiveness (Phase 2)UnknownNCT00669292
What this trial is testing

PhaseⅠ/Ⅱ Study of URLC10-177 and TTK-567 Peptide Vaccine Combined With CpG7909 in Patients With Esophageal Cancer

Who this might be right for
Esophageal Cancer
Wakayama Medical University 29
Testing effectiveness (Phase 2)Looking for participantsNCT06929936
What this trial is testing

Trilaciclib in Combination With Docetaxel for Second-Line and Beyond Treatment of Locally Advanced or Metastatic NSCLC

Who this might be right for
Non-Small Cell Lung CancerMyelosuppression
The First Affiliated Hospital of Xiamen University 33
Testing effectiveness (Phase 2)Looking for participantsNCT06827236
What this trial is testing

A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer

Who this might be right for
Locally Advanced Breast CancerUnresectable Breast CarcinomaMetastatic Breast Cancer
BioNTech SE 380
Testing effectiveness (Phase 2)Active Not RecruitingNCT03523312
What this trial is testing

Use of High-dose Radiation Therapy Plus Chemotherapy to Improve the Likelihood of Surgical Treatment in Patients With Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Memorial Sloan Kettering Cancer Center 47
Large-scale testing (Phase 3)Study completedNCT01631565
What this trial is testing

Early Incorporation of Patient and Family to Attention and Care Program in Oncology Versus Standard of Care

Who this might be right for
Lung Neoplasms
Instituto Nacional de Cancerologia de Mexico 201
Testing effectiveness (Phase 2)Looking for participantsNCT06056336
What this trial is testing

Perioperative Tislelizumab Plus Chemotherapy for Resectable Thoracic Oesophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell CarcinomaNeoadjuvant ChemoimmunotherapyAdjuvant Therapy
Guo Xufeng 73
Not applicableLooking for participantsNCT06831981
What this trial is testing

Hyperthermia With Chemoradiotherapy in Rectal Cancer

Who this might be right for
Rectal Cancer
University Hospital Tuebingen 264
Testing effectiveness (Phase 2)Looking for participantsNCT07106892
What this trial is testing

Phase II, Open-label, Multicenter Study to Evaluate the Efficacy and Safety of HLX43 (an Anti-PD-L1 ADC) in Subjects With Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer (CRC)
Shanghai Henlius Biotech 60
Testing effectiveness (Phase 2)UnknownNCT06543836
What this trial is testing

CtDNA-guided Treatment of TKI Plus PD-1 Inhibitor for Advanced pMMR/MSS Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 68
Testing effectiveness (Phase 2)Study completedNCT01653028
What this trial is testing

Alisertib in Treating Patients With Advanced or Metastatic Sarcoma

Who this might be right for
MyxofibrosarcomaRecurrent Adult Soft Tissue SarcomaRecurrent Leiomyosarcoma+5 more
National Cancer Institute (NCI) 72
Testing effectiveness (Phase 2)Study completedNCT00704158
What this trial is testing

Study of CR011-vcMMAE to Treat Locally Advanced or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
CuraGen Corporation 42
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07574047
What this trial is testing

MELCHRONO: A Prospective Randomized Study Investigating Chrono-immunotherapy for Advanced Melanoma.

Who this might be right for
MelanomaAdvanced Melanoma
Swiss Cancer Institute 108
Early research (Phase 1)Looking for participantsNCT05104515
What this trial is testing

First-in-human Study of OVM-200 as a Therapeutic Cancer Vaccine

Who this might be right for
Prostate CancerNon Small Cell Lung CancerOvarian Cancer
Oxford Vacmedix UK Ltd. 36
Testing effectiveness (Phase 2)Ended earlyNCT00073008
What this trial is testing

Oral GW572016 In Advanced Or Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer, Non-Small Cell
GlaxoSmithKline 131
Testing effectiveness (Phase 2)UnknownNCT00005876
What this trial is testing

Nitrocamptothecin in Treating Patients With Locally Advanced or Metastatic Stomach Cancer That Cannot Be Removed During Surgery

Who this might be right for
Esophageal CancerGastric Cancer
Astex Pharmaceuticals, Inc.
Testing effectiveness (Phase 2)Study completedNCT03312738
What this trial is testing

Everolimus Plus Exemestane in Chinese Postmenopausal Women With Estrogen Receptor Positive, Locally Advanced, Recurrent, or Metastatic Breast Cancer After Recurrence or Progression on Non-steroidal Aromatase Inhibitor

Who this might be right for
Advanced Breast Cancer
Novartis Pharmaceuticals 159
Testing effectiveness (Phase 2)Study completedNCT01139138
What this trial is testing

Safety Study of the Combination of Panitumumab, Irinotecan and Everolimus in the Treatment of Advanced Colorectal Cancer

Who this might be right for
Colorectal CancerColorectal CarcinomaColorectal Tumors+1 more
The Queen Elizabeth Hospital 49
Next Page